Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $1,549,944 |
Sells | 169 | $15,948,143 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
20 Jun 2024 17:56 | AVTE | Aerovate Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 17 Jun 2024 | Purchase | 928,110 | 1.67 | 1,549,944 | I |
20 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 18 Mar 2024 | Sale | 27,476 | 25.7418 | 707,282 | D |
08 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Dec 2022 | Sale | 36,115 | 17.8004 | 642,861 | D |
11 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 07 Mar 2024 | Sale | 22,386 | 25.0017 | 559,688 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 01 Apr 2024 | Sale | 12,495 | 31.2291 | 390,208 | D |
14 Jun 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 14 Jun 2024 | Sale | 15,000 | 25.03 | 375,450 | D |
11 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GRAYZEL DAVID S. | Director | 09 Apr 2024 | Sale | 11,882 | 28.15 | 334,478 | I |
05 Jan 2023 17:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 03 Jan 2023 | Sale | 11,927 | 26.7973 | 319,611 | D |
28 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 27 Mar 2024 | Sale | 11,068 | 27.9652 | 309,519 | D |
03 May 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 May 2023 | Sale | 15,000 | 20.6059 | 309,088 | D |
13 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 12 Dec 2022 | Sale | 10,000 | 30.0428 | 300,428 | D |
02 Dec 2022 19:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Dec 2022 | Sale | 15,000 | 18 | 270,000 | D |
09 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 08 Dec 2022 | Sale | 11,031 | 24.2022 | 266,974 | D |
01 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 28 Mar 2024 | Sale | 9,000 | 29.5 | 265,500 | D |
14 Jun 2024 18:00 | AVTE | Aerovate Therapeutics Inc | VERWIJS MARINUS | CHIEF TECHNICAL OFFICER | 14 Jun 2024 | Sale | 10,600 | 25 | 265,000 | D |
14 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 09 Nov 2022 | Sale | 14,000 | 17.9055 | 250,677 | D |
08 Mar 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Mar 2023 | Sale | 10,067 | 23.7098 | 238,687 | D |
03 Feb 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Feb 2023 | Sale | 10,505 | 22.5213 | 236,586 | D |
11 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 07 Mar 2024 | Sale | 8,975 | 24.5 | 219,888 | D |
08 Feb 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Feb 2023 | Sale | 8,858 | 24.5205 | 217,203 | D |
27 Nov 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 22 Nov 2023 | Sale | 13,800 | 15 | 207,000 | D |
29 Nov 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 27 Nov 2023 | Sale | 12,517 | 16.2369 | 203,237 | D |
20 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 18 Mar 2024 | Sale | 7,581 | 26.4825 | 200,764 | D |
09 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 07 Nov 2022 | Sale | 11,122 | 17.7863 | 197,819 | D |
15 Dec 2023 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 14 Dec 2023 | Sale | 9,897 | 19.5 | 192,992 | D |
09 Jan 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Jan 2023 | Sale | 7,492 | 25.6205 | 191,949 | D |
09 May 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 08 May 2023 | Sale | 8,685 | 21.6241 | 187,805 | D |
17 May 2024 19:10 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 16 May 2024 | Sale | 8,707 | 21.5241 | 187,410 | D |
07 Apr 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Apr 2023 | Sale | 10,283 | 18.1687 | 186,829 | D |
03 May 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 9,035 | 20.3423 | 183,793 | D |
12 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 10 Apr 2024 | Sale | 6,729 | 26.7706 | 180,139 | D |
05 Jul 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 03 Jul 2023 | Sale | 10,000 | 18 | 180,000 | D |
05 Apr 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 03 Apr 2023 | Sale | 9,172 | 19.155 | 175,690 | D |
11 Oct 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Oct 2022 | Sale | 11,210 | 15.6418 | 175,345 | D |
07 Jul 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Jul 2023 | Sale | 10,283 | 16.657 | 171,284 | D |
08 Jun 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Jun 2023 | Sale | 10,268 | 16.2798 | 167,161 | D |
07 Dec 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Dec 2023 | Sale | 10,283 | 16.107 | 165,628 | D |
20 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 18 Mar 2024 | Sale | 6,387 | 25.8137 | 164,872 | D |
09 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 08 Nov 2022 | Sale | 8,373 | 18.0888 | 151,458 | D |
09 Aug 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 07 Aug 2023 | Sale | 9,742 | 15.4785 | 150,792 | D |
14 Jun 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 13 Jun 2024 | Sale | 6,000 | 24.5 | 147,000 | D |
19 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 17 Apr 2024 | Sale | 6,447 | 22.3151 | 143,865 | D |
27 Nov 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 22 Nov 2023 | Sale | 9,382 | 15.1736 | 142,359 | D |
11 Oct 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 07 Oct 2022 | Sale | 8,763 | 15.9342 | 139,631 | D |
18 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 16 Apr 2024 | Sale | 5,509 | 24.9428 | 137,410 | D |
09 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 07 Dec 2022 | Sale | 7,079 | 19.3657 | 137,090 | D |
03 Mar 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Mar 2023 | Sale | 5,962 | 22.7071 | 135,380 | D |
03 Mar 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Mar 2023 | Sale | 5,316 | 24.6878 | 131,240 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Apr 2024 | Sale | 4,502 | 28.9647 | 130,399 | D |
20 Oct 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 18 Oct 2022 | Sale | 5,705 | 21.0844 | 120,287 | D |
05 Apr 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 03 Apr 2023 | Sale | 5,828 | 19.7712 | 115,227 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | VERWIJS MARINUS | CHIEF TECHNICAL OFFICER | 01 Apr 2024 | Sale | 3,796 | 28.8669 | 109,579 | D |
18 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 16 Apr 2024 | Sale | 4,491 | 24.3956 | 109,561 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 01 Apr 2024 | Sale | 3,325 | 31.9749 | 106,317 | D |
03 Feb 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Feb 2023 | Sale | 4,495 | 23.0502 | 103,611 | D |
01 Aug 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 28 Jul 2023 | Sale | 5,478 | 18 | 98,604 | D |
27 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 25 Mar 2024 | Sale | 3,432 | 28.0068 | 96,119 | D |
09 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 07 Dec 2022 | Sale | 4,558 | 20.4021 | 92,993 | D |
14 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 11 Nov 2022 | Sale | 4,452 | 20.3851 | 90,754 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Apr 2024 | Sale | 2,851 | 31.0228 | 88,446 | D |
11 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 11 Mar 2024 | Sale | 3,423 | 25.2423 | 86,404 | D |
18 Oct 2022 17:01 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 17 Oct 2022 | Sale | 4,185 | 20.1624 | 84,380 | D |
17 May 2024 19:10 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 17 May 2024 | Sale | 3,914 | 21.0658 | 82,452 | D |
19 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 17 Apr 2024 | Sale | 3,689 | 22.3006 | 82,267 | D |
13 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 09 Dec 2022 | Sale | 3,386 | 24.2335 | 82,055 | D |
19 Jul 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 17 Jul 2023 | Sale | 4,522 | 18.1106 | 81,896 | D |
07 Feb 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Feb 2024 | Sale | 4,600 | 17.4455 | 80,249 | D |
19 Jan 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 17 Jan 2024 | Sale | 4,000 | 19.5 | 78,000 | D |
22 Dec 2023 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 20 Dec 2023 | Sale | 4,000 | 19.5 | 78,000 | D |
25 Apr 2023 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 21 Apr 2023 | Sale | 4,000 | 19.5 | 78,000 | D |
27 Nov 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 24 Nov 2023 | Sale | 4,920 | 15.7364 | 77,423 | D |
12 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 08 Dec 2022 | Sale | 3,178 | 24.0821 | 76,533 | D |
09 Jan 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Jan 2023 | Sale | 2,792 | 26.9534 | 75,254 | D |
07 Dec 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Dec 2023 | Sale | 4,600 | 16.3034 | 74,996 | D |
20 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | VERWIJS MARINUS | CHIEF TECHNICAL OFFICER | 19 Mar 2024 | Sale | 2,764 | 26.4558 | 73,124 | D |
12 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 08 Dec 2022 | Sale | 3,199 | 22.5628 | 72,178 | D |
20 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | VERWIJS MARINUS | CHIEF TECHNICAL OFFICER | 19 Mar 2024 | Sale | 2,536 | 25.6779 | 65,119 | D |
03 Mar 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Mar 2023 | Sale | 2,672 | 23.8109 | 63,623 | D |
05 Jan 2023 17:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 03 Jan 2023 | Sale | 2,267 | 27.9028 | 63,256 | D |
09 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 07 Nov 2022 | Sale | 3,359 | 18.5768 | 62,399 | D |
09 Jan 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Jan 2023 | Sale | 2,250 | 26.402 | 59,404 | D |
08 Sep 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 06 Sep 2023 | Sale | 3,931 | 15.0564 | 59,187 | D |
12 Oct 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 10 Oct 2022 | Sale | 3,524 | 16.7401 | 58,992 | D |
12 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 08 Dec 2022 | Sale | 2,695 | 21.6335 | 58,302 | D |
08 Feb 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 06 Feb 2023 | Sale | 2,250 | 24.272 | 54,612 | D |
08 Mar 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 06 Mar 2023 | Sale | 2,205 | 23.727 | 52,318 | D |
22 Feb 2024 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 20 Feb 2024 | Sale | 2,591 | 20.1068 | 52,097 | D |
14 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 12 Mar 2024 | Sale | 2,051 | 25.0461 | 51,370 | D |
14 Mar 2024 18:00 | AVTE | Aerovate Therapeutics Inc | ELDRIDGE GEORGE A | SEE REMARKS | 13 Mar 2024 | Sale | 2,016 | 25.0223 | 50,445 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | 01 Apr 2024 | Sale | 1,647 | 29.8955 | 49,238 | D |
08 Jan 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Jan 2024 | Sale | 2,474 | 19.5718 | 48,421 | D |
03 Apr 2024 18:00 | AVTE | Aerovate Therapeutics Inc | VERWIJS MARINUS | CHIEF TECHNICAL OFFICER | 01 Apr 2024 | Sale | 1,504 | 29.999 | 45,118 | D |
09 May 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 May 2023 | Sale | 2,045 | 20.793 | 42,522 | D |
03 May 2024 18:00 | AVTE | Aerovate Therapeutics Inc | VERWIJS MARINUS | CHIEF TECHNICAL OFFICER | 02 May 2024 | Sale | 1,981 | 21.015 | 41,631 | D |
15 Dec 2023 18:00 | AVTE | Aerovate Therapeutics Inc | GILLIES HUNTER | CHIEF MEDICAL OFFICER | 13 Dec 2023 | Sale | 2,103 | 19.5 | 41,008 | D |
08 Jan 2024 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Jan 2024 | Sale | 2,126 | 18.6713 | 39,695 | D |
07 Dec 2022 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Dec 2022 | Sale | 2,250 | 17.384 | 39,114 | D |
07 Jun 2023 18:00 | AVTE | Aerovate Therapeutics Inc | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | 05 Jun 2023 | Sale | 2,250 | 16.256 | 36,576 | D |
09 May 2023 18:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 08 May 2023 | Sale | 1,599 | 22.7358 | 36,355 | D |
14 Nov 2022 17:00 | AVTE | Aerovate Therapeutics Inc | DAKE BENJAMIN T | SEE REMARKS | 10 Nov 2022 | Sale | 1,800 | 20.0955 | 36,172 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)